These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 436143)

  • 21. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L; Kŭnev K
    Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of gout with alternate-day hypo-uricaemic drugs.
    Nishizawa T; Nishida Y; Masuda T; Akaoka I
    Rheumatol Rehabil; 1978 Aug; 17(3):143-9. PubMed ID: 705170
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M
    ZFA (Stuttgart); 1982 Feb; 58(5):296-300. PubMed ID: 7043937
    [No Abstract]   [Full Text] [Related]  

  • 26. Benzbromarone as a long-term uricosuric agent.
    Bluestone R; Klinenberg J; Lee IK
    Adv Exp Med Biol; 1980; 122A():283-6. PubMed ID: 6999849
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy and tolerance of a new benzbromarone preparation].
    Jelke K; Neubauer M; Krause G; Jüttner A; Angar T; Grosse-Kielisch C; Bach GL
    Med Welt; 1980 May; 31(21):821-2. PubMed ID: 7392938
    [No Abstract]   [Full Text] [Related]  

  • 28. Benzbromarone therapy in management of refractory gout.
    Kumar S; Ng J; Gow P
    N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 30. The action of benzbromarone in relation to age, sex and accompanying diseases.
    Ferber H; Bader U; Matzkies F
    Adv Exp Med Biol; 1980; 122A():287-94. PubMed ID: 6999850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of benzbromarone: a new uricosuric drug.
    Sorensen LB; Levinson DJ
    Arthritis Rheum; 1976; 19(2):183-90. PubMed ID: 1259799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapeutical action on arteriosclerotic vascular diseases with benzarone (author's transl)].
    Mörl H; Diehm C; Zimmermann R; Schöffel G; Walter E
    MMW Munch Med Wochenschr; 1980 Feb; 122(8):277-80. PubMed ID: 6767967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical followup of the uricosuric drug--benzbromaron (author's transl)].
    Dzúrik R; Fedelesová V; Danĕková H; Hlavatá E
    Bratisl Lek Listy; 1980 Nov; 74(5):547-54. PubMed ID: 7448590
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Yamamoto A; Moriwaki Y; Masuzaki H; Yamamoto T
    Horm Metab Res; 2009 Apr; 41(4):327-32. PubMed ID: 19048458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of benzbromarone in serum following combined therapy with allopurinol and benzbromarone (author's transl)].
    Nitsche V; Mascher H
    Arzneimittelforschung; 1981; 31(3):510-2. PubMed ID: 7194674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
    Schräpler P; Kleinschmidt A; Haese E
    Med Klin; 1978 Jun; 73(23):861-6. PubMed ID: 661730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic gout. Case report of a severe course of disease].
    Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
    Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug modification of a risk factor of thrombosis in patients with varicosis].
    Haas S; von Eckstädt AV; Lill G; Weichenmeier I; Blümel G
    Fortschr Med; 1982 Aug; 100(30):1418-22. PubMed ID: 7129301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.